Indian IPO Blog: IPO Recommendations
Showing posts with label IPO Recommendations. Show all posts
Showing posts with label IPO Recommendations. Show all posts

Thursday, December 19, 2019

Prince Pipes IPO Reviews - Is it worth applying? What do brokerage houses recommend?

December 19, 2019 0
Prince Pipes IPO Reviews - Is it worth applying? What do brokerage houses recommend?
Prince Pipes IPO opened for subcription from Wednesday. At the price band of Rs 177-178 per share, the IPO is demanding a PE multiple of 23.5 times on a trailing basis.

Is it worth to apply for Prince Pipes IPO? Here are some reviews:

Reliance Securities: Subscribe
“It has healthy return ratios with average RoE of 22 per cent and RoCE of 20 per cent for the same period. Assuming revenue growth of 13 per cent CAGR through FY19-21E, the company is valued at 14 times of FY21E earnings, which appears to be justified considering its business model, steady growth and healthy return ratios. Hence, we recommend subscribe to the issue,” Reliance Securities.

Equirus Securities: Subscribe
“Construction ban in certain areas in North India will impact near-term growth. Post anti-dumping duty on CPVC resin from China/Korea, Prince was forced to raise CPVC price higher than others and this will impact growth/profitability,” it said. However, the brokerage said that there is a chance of “one-time valuation jump to IPO investors.”

Investmentz (Asit C Mehta): Subcribe
“With superior product mix, established brand name, strong distribution network, and adding capacities, we believe Prince Pipes is well placed to capitalize on domestic opportunities. At the upper price band of Rs178, the stock trades at 19.22 times its FY19 EPS of Rs 9.26,” it said

Ventura Securities: Subscribe for listing gains
Ventura Securities expects revenue, Ebitda and PAT of the company to grow at a CAGR of 5 per cent, 14 per cent and 18 per cent, respectively. For FY21, the stock is available at the offer price of 177-178 at 16 times on a fully diluted basis, this brokerage estimated.

BP Wealth: Do not subscribe
"Taking into account its debt position and the increased competitiveness of the market it operates in, the stock does not look attractive. We give ‘Avoid’ rating for the IPO,” it said.

Sunday, November 24, 2019

CSB Bank IPO Review - Is it worth to apply?

November 24, 2019 0
CSB Bank IPO Review - Is it worth to apply?
CSB Bank IPO is open for subscription from November 22 and the IPO has been subscribed fully.
The issue will close on November 26. Equity shares are proposed to be listed on the BSE, as well as the National Stock Exchange on December 4

Is it worth subscribing to CSB Bank IPO? Here's what expert brokerages have to say:

1. HDFC Securities Review on CSB Bank IPO

As per HDFC Securities, the bank's business and financial performance could suffer if it is unable to effectively manage the level of its NPAs.

"Although CSB Bank is making efforts to improve collections and to foreclose on existing impaired loans in a timely manner, there cannot be any assurance that it will be successful in its efforts or that the overall quality of its Bank’s loan portfolio will improve or will not deteriorate in the future," HDFC Securities said.

Issued notices and initiated various recovery proceedings against defaulting borrowers under the SARFAESI Act are also among key concerns, HDFC Securities said.


Moreover, CSB’s funding requirements are primarily met through customer deposits. If it fails to sustain or achieve growth of its deposit base, including its current and savings account deposit base, its business may be adversely affected, HDFC Securities said.


2. IndiaNivesh Review on CSB Bank IPO

IndiaNivesh recommends subscribing to CSB IPO.


"CSB Bank has seen a remarkable turnaround after the new promoter took charge of its affairs in FY19. At the upper end of the issue price, it is available at P/BV of around 2.19 times on ‘TTM’ basis. We expect CSB Bank to embark on a growth trajectory of over 20 percent on business and profitability for the next couple of years. There is ample scope for it to get re-rated at higher a multiple of 2.5 times to 2.7 times P/BV after listing," said IndiaNivesh.


3. BP Securities Review on CSB Bank IPO

BP Equities recommends subscribing to the issue.

"CSB has posted turnaround results in six months of FY20 and has improved its operational and financial performance. We believe the bank should do well with the recent capital raise and its strong risk management frameworks. We give subscribe rating to the IPO," said the brokerage firm.


"On the valuation front, at the upper end of the price band, CSB is valued at 2.31 times P/BV and 25.31 times P/E. Taking into account huge growth prospects and its comfortable asset quality, the stock looks attractive for investment," said BP Equities.


Wednesday, August 8, 2018

Creditaccess Grameen IPO opens - Should you apply? Brokerage Analysts Recommendations

August 08, 2018 0
Creditaccess Grameen IPO opens - Should you apply? Brokerage Analysts Recommendations
Brokerage recommendations for Creditaccess Grameen IPO

Antique Broking
Recommends ‘Avoid’.
Geographic concentration, lack of technology and people, and its inability to offer beyond joint lending group loans raises questions on long-term competitive positioning.
Valuations do not leave investors with much margin of safety.

Emkay Global
Recommends ‘Avoid’.
Valuations doesn’t justify adherent business risks and low returns on equity.

SMC Global
Recommends ‘Subscribe’.
While 11.8 percent return on equity for 2017-18 is still sub-optimal compared to some of the large MFIs, the valuation adequately captures this and any improvement in the return on equity will aid further valuations.

Prabhudas Lilladher
Recommends ‘Subscribe’ for long term.
Expensive valuations and high business concentration risks are key deterrents
Improvement of return on equity is crucial
Listing gains may be limited.


Join Indian IPO Blog Whatsapp groups for discussing and news, views and updates

Friday, January 26, 2018

Galaxy Surfactants IPO Review - Indian IPO Blog

January 26, 2018 0
Galaxy Surfactants IPO Review - Indian IPO Blog
Galaxy Surfactants Limited is a Mumbai based manufacturer of surfactants and other specialty ingredients for the personal care and home care industries. The ingredients company manufacture are commonly used in consumer-centric personal care and home care products like skin care, oral care, hair care, cosmetics, toiletries and detergent products. Galaxy Surfactants product portfolio includes over 200 product grades, which are marketed to over 1,700 customers in 70 countries

Galaxy Surfactants products are classified in 2 categories:
1. Performance Surfactants: This includes anionic surfactants and non-ionic surfactants.
2. Speciality Care Products: This includes amphoteric surfactants, cationic surfactants, UV filters, preservatives, preservative blends and surfactant blends, speciality ingredients such as mild surfactants, syndet and transparent bathing bars and proteins, fatty alkanolamides and fatty acid esters, and other care products.

Customers include Cavinkare Private Limited, Colgate-Palmolive (India) Limited, Dabur India Limited, Henkel, Himalaya, LOREAL, Procter & Gamble Home Products Private Limited, Reckitt Benckiser and Unilever

Red flag: The company tried to raise money in 2011 but failed as only 30% subscription was garnered

Galaxy Surfactants IPO - Issue information
Date : Jan 29, 2018 – Jan 31, 2018.
Issue Price: Rs 1470 – Rs 1480, minimum lot of 10 shares.
Issue Size:  937.09 Cr
Objects of Issue: The issue is total offer for sale. No money will be received by the company.

Risks in Galaxy Surfactants IPO
  • As of September 30, 2017, they conducted operations through seven manufacturing facilities and one pilot plant.
  • They do not have long-term agreements with suppliers for their raw materials.
  • For the six months ended September 30, 2017 and the Fiscals 2017, 2016 and 2015,  cost of materials consumed was ₹7,976.96 million, ₹15,144.88 million, ₹11,153.65 million and ₹12,532.98 million, or 66.63%, 69.74%, 61.66% and 66.81% of  total revenue, respectively.
  • They currently generate a significant portion of  revenues from limited number of major customers. For the six months ended September 30, 2017 and the Fiscals 2017, 2016 and 2015, the top ten customers contributed ₹6,977.65 million, ₹11,833.64 million, ₹9,642.79 million and ₹11,252.47 million, or 58.51%, 54.75%, 53.51% and 60.05% of  total revenues from operations, respectively

Strengths in Galaxy Surfactants IPO
  • Established Global Supplier to Major FMCG Brands with Demonstrated Track Record.
  • Robust Product Portfolio Addressing Diverse Customer Needs.
  • Proven R&D Capabilities with Dedicated Focus on Innovation.
  • Global Footprint Supporting Local Reach.
  • Professional and Experienced Management Team

Analysis of Financial Statements:

Balance Sheet:
  • Reserves & Surplus have grown ~3x from 2013 to Sept 2017.
  • One notable observation is that the company has maintained its debt at healthy levels in the recent times.
  • ~25% of total assets are tied up in trade receivables for all the past periods. Perhaps this is a indicator of inefficient collection business.
  • Short term borrowings have also gone up in recent times. We will see if the spillover effect of High Trade receivables and short term borrowings are having an effect on the Cash flow of the business
  • The company has a notable debt to equity ratio trajectory:
Profit & Loss:
  • Strong consolidated growth in revenue observed at around 17% CAGR in past 5 years
  • However, cost of materials consumed form ~70% of the total costs. Any fluctuations in the prices of the same will have direct negative effect
  • EPS Trajectory is strong as shown below:

IPO Valuation:
There are no listed peers to compare the PE ratio. The company is having an EPS of Rs.41.27 at FY17. At this earnings, the PE ratio works out to be 35.80x at the upper end of the price band. Based on last 3 years consolidated restated EPS of Rs.33.46, the PE ratio works out to be 44.20x at the upper end of price band


IPO Recommendation Synopsis:
Although the good financials, increasing profitability trend and improvement in key ratios such as Debt to Equity may warrant a subscribe, investors need to exercise caution especially in the light of risks enlisted above. Although long term investors may be tempted to go for it as a sectoral addition to the portfolio, high listing gains may not be feasible for short term investors considering the PE ratio and no comparable peers around


The article is presented in conjunction with guest writer Aditya Kondawar from  stocksandbiceps.com

    Friday, September 15, 2017

    ICICI Lombard IPO Review

    September 15, 2017 0
    ICICI Lombard IPO Review

    Brief company profile

    ICICI Lombard General Insurance Company Limited is one of the leading private sector general insurance companies in India. It is engaged in general insurance, reinsurance, insurance claims management and investment management. ICICI bank had 64% stake in the venture while Fairfax had 35% in the joint venture. ICICI Lombard General Insurance is the largest private sector general insurance company in India. 

    The company markets assurance products including Car Insurance, Health Insurance, International Travel Insurance, Overseas Student Travel Insurance, Two Wheeler Insurance, Home Insurance and Weather insurance. ICICI Lombard has 249 branches spread across the nation


    Company and Industry propsects

    India's non-life insurance sector grew at an annualised rate of 14.5% between FY11 and FY16, the second fastest among Asian countries. Despite this, the market penetration was poor ­with policy premium was 0.8% of GDP in 2016. 

    The company being the market leader in the industry, has huge potential in terms of growth in long run if efficiently expanded.

    The company has delivered a strong growth in GDPI and has been successfully maintaining its leadership position amongst the private sector non-life insurers through various cycles of industry evolution


    Financials and Valuation

    The company's Gross Written Premium (GWP) was Rs.109.60 billion in fiscal 2017. The company maintained its market leadership in the private sector with an overall market share of 8.4%. It witnessed an increase in policy volumes by 12.21% from 15.80 million in fiscal 2016 to 17.73 million in fiscal 2017.

    ICICI General’s profit before tax increased from Rs 7.08 billion in fiscal 2016 to Rs 9.10 billion in fiscal 2017. ICICI General’s profit after tax increased from Rs.5.07 billion in fiscal 2016 to Rs.7.02 billion in fiscal 2017

    The company has impressive track with ROE with the same being in excess of 17 percent
    While the figures are impressive in terms of performance, yet it would be worthwhile to check what kind of pricing is the company demanding. At the upper end of price band, the company is demanding a price of 46.5 times the earnings per share as on Mar 2017. There is no listed comparable peer for the company

    It is also pertinent to note that Fairfax Financial Holdings sold 12.2 per cent of its stake in the company to certain private equity firms in the month of May 2017 for Rs 2,470 crore, thereby valuing the firm to around Rs. 20,000 crore. At a higher price band of Rs.661, the IPO is demanding a market cap of Rs 30,000 crore which again implies steep valuations


    Synopsis

    While the company prospects appear promising considering the penetration and industry potential, the price at which the company is offering shares is clearly steep. The company is demanding a PE of 46.5 times.

    With no comparable listed peer, price benchmarking becomes highly blurred. The only far-away comparable turns out to be its own group company (ICICI Prudential Life) which is trading at around 36 times its EPS.

    Taking into view the market leading position of the company, the immense potential of the sector and strong trend of elevated ROE, the IPO may turn out to be a good long term bet. And while considering the high liquidity environment prevalent currently, decent listing gain also appears comfortably plausible. However, investors may need to be ready with necessary patience levels and loyalty towards the stock in case things turn turbulent in the short run

    Wednesday, September 6, 2017

    Dixon Technologies IPO - Is it worth subscribing?

    September 06, 2017 0
    Dixon Technologies IPO - Is it worth subscribing?
    The rather steeply valued IPO of Dixon Technologies is open for subscription between Sep 6, 2017 and Sep 8, 2017

    The IPO received welcoming carpet reception from QIBs on Day 1 with the category getting subscribed 1.78 times. If the category gets accelerated response on Day 2 as well, Retail and HNI investors are sure to follow the suit aggressively

    Valuationwise though is the IPO worth? Here's a perspective...

    With a price Band of Rs.1760 to Rs.1766, the PE ratio on the upper band is 41.42 times and there are no listed peers to compare as per RHP. However, if we look for cursory forced peers, Havells sits at PE of 56.83 and V Guard trades at 61.23. Comparatively, Dixon looks relatively humble

    The company has shown a good growth in terms of consolidated Revenue 33.8% in the past 5 years and a respectable  growth in terms of Profit after tax.

    The proceeds are intended to be used for the expansion which is also calming to ears.

    All said and done and also taking into account quasi Euphoria in IPO markets, it may be worthwhile to go for Dixon for Long Term if not as a listing gain earner

    Thursday, August 3, 2017

    Cochin Shipyard IPO closes - Should you go for it?

    August 03, 2017 0
    Cochin Shipyard IPO closes - Should you go for it?
    The initial public offering (IPO) of state-owned Cochin Shipyard Limited was subscribed 3.16 times on its second day of opening
    The IPO is a fresh issue of 22.65 million shares, which at the upper end of the price band will fetch the company over Rs978 crore. There is also an offer for sale of 11.3 million shares. At the upper end of the price band, the government, which is selling 10% stake, will raise over Rs.489 crore

    But whether all this makes a good bet to go for it? Let's find out on a simple 3 point criteria

    1. Company Business prospects

    The company has a strong reputation in the shipbuilding space, particularly in relation to the defence sector. It has been in existence since 1972. In the past it has undertaken repairs of Indian Navy aircraft carriers such as INS Viraat and INS Vikramaditya. It is also building India's first indigenous Aircraft Carrier (IAC) for Indian Navy. It is also one of the few companies with "Miniratna" status
    Cochin Shipyard has a credible moat given that it receives preferential orders from the Indian navy and the coast guard. Being a Government of India company it also receives some confidential orders which can not be given to private players

    2. Financials

    The company's average five year ROE and ROCE were 16.1% and 24.7% respectively. Current ROE and ROCE stand at 16.2% and 23.9% respectively
    The company's revenue increased at a CAGR of 5.7% in last five years. However this growth seems impressive, given the poor health of the shipbuilding industry, excess supply, low demand and volatility in crude prices
    Moreover, the company is effectively debt free and has cash and cash equivalents of around Rs 2,000 crores against estimated capital expenditures of around Rs 2,000 crores over 3-4 years after adjusting for IPO proceeds

    3. Pricing

    The company has set a price band of Rs. 424 to Rs.432 per share for the initial share sale. One of the tempting features especially for Retail investors is the special discount of Rs.21 per equity share which will in turn reduce the cost per share Rs.411 per share assuming allotment is made at upper end of price band.

    The company is best profit making one in the shipbuilding industry since all of its listed peers have negative earnings and are highly leveraged whereas Cochin Shipyard would have a PE ratio of 18.8 times which is fairly justified

    This price is also clearly attractive for listing gains considering already high grey market premium running through

    Verdict

    Considering that the company ticks most of the boxes, investors may not want to miss this ship!